BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25818872)

  • 1. ADAM protease inhibitors reduce melanogenesis by regulating PMEL17 processing in human melanocytes.
    Kawaguchi M; Hozumi Y; Suzuki T
    J Dermatol Sci; 2015 May; 78(2):133-42. PubMed ID: 25818872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice.
    Shimshek DR; Jacobson LH; Kolly C; Zamurovic N; Balavenkatraman KK; Morawiec L; Kreutzer R; Schelle J; Jucker M; Bertschi B; Theil D; Heier A; Bigot K; Beltz K; Machauer R; Brzak I; Perrot L; Neumann U
    Sci Rep; 2016 Feb; 6():21917. PubMed ID: 26912421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toll-like receptor 4 activation inhibits melanogenesis in melanocytes].
    Sun L; Sun J; Huo X; Li Y; Li Y; Xie X; Hu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1466-1470. PubMed ID: 27774936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells.
    Rochin L; Hurbain I; Serneels L; Fort C; Watt B; Leblanc P; Marks MS; De Strooper B; Raposo G; van Niel G
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10658-63. PubMed ID: 23754390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA-mediated knock-down of COX-2 in melanocytes suppresses melanogenesis.
    Kim JY; Shin JY; Kim MR; Hann SK; Oh SH
    Exp Dermatol; 2012 Jun; 21(6):420-5. PubMed ID: 22506937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling the Potential of Ultrasonic-Assisted Ethanol Extract from
    Kirindage KGIS; Jayasinghe AMK; Ko CI; Ahn YS; Heo SJ; Oh JY; Kim EA; Cha SH; Ahn G
    Front Biosci (Landmark Ed); 2024 May; 29(5):194. PubMed ID: 38812330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells.
    Ancans J; Tobin DJ; Hoogduijn MJ; Smit NP; Wakamatsu K; Thody AJ
    Exp Cell Res; 2001 Aug; 268(1):26-35. PubMed ID: 11461115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inulavosin, a melanogenesis inhibitor, leads to mistargeting of tyrosinase to lysosomes and accelerates its degradation.
    Fujita H; Motokawa T; Katagiri T; Yokota S; Yamamoto A; Himeno M; Tanaka Y
    J Invest Dermatol; 2009 Jun; 129(6):1489-99. PubMed ID: 19110539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diethylstilbestrol enhances melanogenesis via cAMP-PKA-mediating up-regulation of tyrosinase and MITF in mouse B16 melanoma cells.
    Jian D; Jiang D; Su J; Chen W; Hu X; Kuang Y; Xie H; Li J; Chen X
    Steroids; 2011 Nov; 76(12):1297-304. PubMed ID: 21745488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine levels regulate the melanogenic response to alpha-melanocyte-stimulating hormone in human melanocytes: implications for pigmentation and proliferation.
    Schwahn DJ; Xu W; Herrin AB; Bales ES; Medrano EE
    Pigment Cell Res; 2001 Feb; 14(1):32-9. PubMed ID: 11277492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partially purified Curcuma longa inhibits alpha-melanocyte-stimulating hormone-stimulated melanogenesis through extracellular signal-regulated kinase or Akt activation-mediated signalling in B16F10 cells.
    Jang JY; Lee JH; Jeong SY; Chung KT; Choi YH; Choi BT
    Exp Dermatol; 2009 Aug; 18(8):689-94. PubMed ID: 19469902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced glutathione disrupts the intracellular trafficking of tyrosinase and tyrosinase-related protein-1 but not dopachrome tautomerase and Pmel17 to melanosomes, which results in the attenuation of melanization.
    Nakajima H; Nagata T; Koga S; Imokawa G
    Arch Dermatol Res; 2014 Jan; 306(1):37-49. PubMed ID: 23764898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of Pmel17 amyloid is regulated by juxtamembrane metalloproteinase cleavage, and the resulting C-terminal fragment is a substrate for gamma-secretase.
    Kummer MP; Maruyama H; Huelsmann C; Baches S; Weggen S; Koo EH
    J Biol Chem; 2009 Jan; 284(4):2296-306. PubMed ID: 19047044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin inhibits α-MSH-stimulated melanogenesis in B16F10 melanoma cells.
    Yang YM; Son YO; Lee SA; Jeon YM; Lee JC
    Phytother Res; 2011 Aug; 25(8):1166-73. PubMed ID: 21290442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylic acid in ginseng root alleviates skin hyperpigmentation disorders by inhibiting melanogenesis and melanosome transport.
    Liu J; Jiang R; Zhou J; Xu X; Sun Z; Li J; Chen X; Li Z; Yan X; Zhao D; Zheng Z; Sun L
    Eur J Pharmacol; 2021 Nov; 910():174458. PubMed ID: 34480884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro melanogenesis inhibitory effects of N-feruloyldopamine.
    Leoty-Okombi S; Bonnet S; Rival D; Degrave V; Lin X; Vogelgesang B; André-Frei V
    J Cosmet Sci; 2013; 64(2):133-44. PubMed ID: 23578836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of PMEL attenuates melanization via activating lysosomes and degradation of tyrosinase by lysosomes.
    Sun L; Hu L; Zhang P; Li H; Sun J; Wang H; Xie X; Hu J
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2536-2542. PubMed ID: 30208522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation.
    Martínez-Esparza M; Ferrer C; Castells MT; García-Borrón JC; Zuasti A
    Int J Biochem Cell Biol; 2001 Oct; 33(10):971-83. PubMed ID: 11470231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inhibitory mechanism of action of a novel syringic-acid derivative on α-melanocyte-stimulating hormone (α-MSH)-induced melanogenesis.
    Jeong YJ; Lee JY; Park J; Park SN
    Life Sci; 2017 Dec; 191():52-58. PubMed ID: 28993145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.
    Bakken AM; Protack CD; Roztocil E; Nicholl SM; Davies MG
    J Vasc Surg; 2009 May; 49(5):1296-303. PubMed ID: 19394555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.